| abstract |
(57) Abstract: TNF comprising a combination of an insulin sensitizer and an HMG-CoA reductase inhibitor, which is useful as a prophylactic / therapeutic agent for diseases involving TNF-α, such as inflammatory diseases. -To provide an alpha inhibitor. An insulin sensitizer and HMG-CoA are provided. A TNF-α inhibitor comprising a combination with a reductase inhibitor. |